MILLENNIUM INVESTIGATOR INITIATED STUDIES

Millennium: the Takeda Oncology Company supports selected high-quality proposals of research that are (1) strategically aligned with our development needs, (2) are submitted by qualified, independent investigators (and organizations) who function as the Sponsor for the proposed study (Investigator-Initiated Studies, or IIS), and (3) fall within budget constraints. Applications for grant support in the form(s) of funding, Millennium/Takeda oncology study drug supply, and/or other in-kind support may be applied for.

Please be aware that grant commitments can only be made by our IIS Review Committee after review of both proposed science and a detailed budget form.

Important: Applicant influence in the marketplace, purchasing patterns, history of advocacy or other such commercial considerations are not included in grant decisions. Inclusion of such information in grant application materials will result in pro forma rejection of the application.

For more information or assistance regarding Investigator-Initiated Study Programs, please contact us at: iismanagement@mpi.com.